Send password reminder...
Subscribe to New Research on CK 2289
inotropic agent with potential utility in treatment of congestive heart failure; structure given in first source; RN from Toxlit
Also Known As:
relevant articles (
Bio-Agent Context: Research Results
Heterocyclic Compounds: 60
1-Ring Heterocyclic Compounds
CK 2289: 1
01/01/1991 - "
CK-2289 is an inhibitor of type III cyclic 3'5'-adenosine monophosphate phosphodiesterase with potential utility in the treatment of congestive heart failure.
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
We wish to acknowledge and thank the US National Library of Medicine and Medline staff for providing access to their data.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.